IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Drugs in Context

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

2.82

h-Index

2022-2023

 32

Rank

2022-2023

 5506

SJR

2022-2023

 0.845

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Drugs in Context
Abbreviation Drugs Context
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Pharmacology (Q2)
h-index 32
Overall Rank/Ranking 5506
SCImago Journal Rank (SJR) 0.845
Impact Score 2.82
Publisher BioExcel Publishing Ltd.
Country United Kingdom
ISSN 17404398, 17451981
Best Quartile Q2
Coverage History 2006-2008, 2012-2022




About Drugs in Context


Drugs in Context is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Pharmacology (Q2). It is published by BioExcel Publishing Ltd.. The overall rank of Drugs in Context is 5506. According to SCImago Journal Rank (SJR), this journal is ranked 0.845. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 32. The best quartile for this journal is Q2.

The ISSN of Drugs in Context journal is 17404398, 17451981. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drugs in Context is cited by a total of 705 articles during the last 3 years (Preceding 2022).


Drugs in Context Impact IF 2022-2023


The Impact IF 2022 of Drugs in Context is 2.82, which is computed in 2023 as per its definition. Drugs in Context IF is decreased by a factor of 2.01 and approximate percentage change is -41.61% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Drugs in Context Impact IF 2023 Prediction


Impact IF 2022 of Drugs in Context is 2.82. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Drugs in Context. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 2.82
2021 4.83
2020 5.70
2019 3.43
2018 1.04
2017 2.94
2016 3.78
2015 1.65
2014 0.94

Drugs in Context h-index


  Table Setting

Drugs in Context has an h-index of 32. It means 32 articles of this journal have more than 32 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Drugs in Context ISSN


The ISSN of Drugs in Context is 17404398, 17451981. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Drugs in Context Rank and SCImago Journal Rank (SJR)


The overall rank of Drugs in Context is 5506. According to SCImago Journal Rank (SJR), this journal is ranked 0.845. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Drugs in Context by Year


Year SJR
2023/2024 Coming Soon
2022 0.845
2021 1.130
2020 1.262
2019 0.848
2018 0.921
2017 1.194
2016 0.718
2015 0.681
2014 0.161

Ranking of Drugs in Context by Year


Year Ranking
2023/2024 Coming Soon
2022 5506
2021 3357
2020 3033
2019 5492
2018 4866
2017 3345
2016 6574
2015 6975
2014 19693

Drugs in Context Publisher


Table Setting

Drugs in Context is published by BioExcel Publishing Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2006-2008, 2012-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Drugs in Context is Drugs Context. This abbreviation ('Drugs Context') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Drugs in Context


If your research field is/are related to Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Pharmacology (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Drugs in Context?

Drugs in Context latest impact IF is 2.82. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.70 (2020) and 0.94 (2014), respectively, in the last 9 years. Moreover, its average IS is 3.01 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Drugs in Context?

The Drugs in Context has an SJR (SCImago Journal Rank) of 0.845, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 1.262 in 2020 and the lowest being 0.161 in 2014. Furthermore, the average SJR of the Drugs in Context over the previous 9-year period stands at 3.01.


What's the latest h-index of the Drugs in Context?

The latest h-index of the Drugs in Context is 32.


Who's the publisher of the Drugs in Context?

The Drugs in Context is published by the BioExcel Publishing Ltd., with its country of publication being the United Kingdom.


What's the current ranking of the Drugs in Context?

The Drugs in Context is currently ranked 5506 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 3033 in 2020 and its lowest position of 19693 in 2014.


What's the abbreviation or short name for the Drugs in Context?

The standard ISO4 abbreviation for the Drugs in Context is Drugs Context.


Is the "Drugs in Context" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Drugs in Context is classified as a journal that the BioExcel Publishing Ltd. publishes.


What's the scope or major areas of the Drugs in Context?

The Drugs in Context encompasses the following areas:

  • Medicine (miscellaneous)
  • Molecular Medicine
  • Pharmacology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Drugs in Context?

The Drugs in Context is assigned the following International Standard Serial Numbers (ISSN): 17404398, 17451981.


What's the best quartile of the Drugs in Context?

The best quartile for the Drugs in Context is Q2 (2022).


What's the coverage history of the Drugs in Context?

The Drugs in Context coverage history can be summarized as follows: 2006-2008, 2012-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
SPE Production and Operations Symposium, Proceedings conference and proceedings 15907 21 0.00
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Journal of Business Finance and Accounting journal 3221 Wiley-Blackwell Publishing Ltd 84 3.68
Journal of Classical Sociology journal 13766 SAGE Publications Ltd 27 0.83
Marine Biology Research journal 13573 Taylor and Francis Ltd. 42 1.06
Transnational Corporations journal 6120 UNCTAD United Nations Conference on Trade and Development 27 1.92
Palaeontographica Abteilung B: Palaeophytologie book series 15138 E. Schweizerbart'sche Verlagsbuchhandlung 16 2.20
Educational Measurement: Issues and Practice journal 4494 Wiley-Blackwell Publishing Ltd 59 1.53
Natural Solutions trade journal 28581 Innovision Health Media 1 0.00
Built Environment journal 12797 Alexandrine Press 43 1.15

Check complete list




Year wise Impact Score (IS) of Drugs in Context

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 2.82
2021 4.83
2020 5.70
2019 3.43
2018 1.04
2017 2.94
2016 3.78
2015 1.65
2014 0.94



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Publishing Group | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Genome Medicine
BioMed Central Ltd. | United Kingdom

EMBO Molecular Medicine
Wiley-Blackwell | United Kingdom

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Experimental and Molecular Medicine
Korean Society of Med. Biochemistry and Mol. Biology | South Korea

Molecular Aspects of Medicine
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Pharmacological Reviews
American Society for Pharmacology and Experimental Therapeutics | United States

Drug Resistance Updates
Churchill Livingstone | United States

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd. | United Kingdom

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

See All